Alterity Therapeutics
ATHE
16 hedge funds and large institutions have $902K invested in Alterity Therapeutics in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
88% more capital invested
Capital invested by funds: $481K → $902K (+$421K)
23% more funds holding
Funds holding: 13 → 16 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$174K |
| 2 |
Renaissance Technologies
New York
|
+$95.8K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$91.7K |
| 4 |
GBA
Garrison Bradford & Associates
New York
|
+$77.5K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$42.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$14.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $523K | +$174K | +3,490 | +43% |
|
|
VKH
2
Virtu KCG Holdings
New York
| $89K | +$42.5K | +853 | +76% |
|
|
3
Renaissance Technologies
New York
| $87K | +$95.8K | +1,922 | New |
|
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $83K | +$91.7K | +1,840 | New |
|
|
GBA
5
Garrison Bradford & Associates
New York
| $70K | +$77.5K | +1,555 | New |
|
6
UBS Group
Zurich,
Switzerland
| $23K | +$22.9K | +459 | +765% |
|
|
AIM
7
Advantage Investment Management
Cedar Rapids,
Iowa
| $7K | – | – | – |
|
8
Wells Fargo
San Francisco,
California
| $7K | – | – | – |
|
|
AG
9
Advisor Group
Phoenix,
Arizona
| $4K | – | – | – |
|
|
10
Bank of America
Charlotte,
North Carolina
| $2K | -$14.9K | -300 | -85% |
|
11
Group One Trading
Chicago,
Illinois
| $2K | – | – | – |
|
|
MFS
12
MSI Financial Services
Springfield,
Massachusetts
| $2K | – | – | – |
|
13
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $2K | – | – | – |
|
|
LTFS
14
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | +$997 | +20 | New |
|
ATHE Hedge Fund Activity: Q3 2016 in Review
16 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q3 2016, worth a combined $902K — up 88% from $481K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ATHE positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $174K. The largest seller was Bank of America, cutting an estimated $14.9K.
- 16 institutional investors held Alterity Therapeutics (ATHE) as of Q3 2016, up from 13 in Q2 2016.
- Funds reported $902K of Alterity Therapeutics stock for Q3 2016, up 88% quarter-over-quarter.
- 4 funds opened new Alterity Therapeutics positions in Q3 2016 and 1 closed out, a net change of +3 holders.
- The largest Alterity Therapeutics buyer in Q3 2016 was Morgan Stanley, an estimated $174K added.
- The largest Alterity Therapeutics seller in Q3 2016 was Bank of America, an estimated $14.9K sold.
Based on aggregated 13F filings for Q3 2016.